United States: Mintz IRA Update — Removal Of AMP-Cap On Medicaid Rebates Causes Insulin Price Decrease - Mintz

United States: Mintz IRA Update — Removal Of AMP-Cap On Medicaid Rebates Causes Insulin Price Decrease - Mintz

Mondaq

Published

Insulin costs lowered to $35 dollars per month for many patients this year as three major insulin manufacturers — Sanofi, Novo Nordisk...

Full Article